Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Allison Naleway and Mark Schmidt.
Allison Naleway
Connection Strength
2.053
Mark Schmidt
  1. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. J Adolesc Health. 2013 Nov; 53(5):637-41.
    View in: PubMed
    Score: 0.449
  2. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010 Nov 16; 28(49):7713-5.
    View in: PubMed
    Score: 0.362
  3. Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S162-S166.
    View in: PubMed
    Score: 0.245
  4. Attitudes toward a future norovirus vaccine among members of an integrated healthcare delivery system in Portland, Oregon, 2016-2017. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2317599.
    View in: PubMed
    Score: 0.230
  5. CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design. BMJ Open. 2023 Jul 14; 13(7):e071446.
    View in: PubMed
    Score: 0.220
  6. A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system. PLoS One. 2018; 13(8):e0201805.
    View in: PubMed
    Score: 0.156
  7. Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort - Oregon and Washington, 2022-2024. MMWR Morb Mortal Wkly Rep. 2025 Apr 03; 74(11):188-193.
    View in: PubMed
    Score: 0.062
  8. Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023. Clin Infect Dis. 2025 Mar 14.
    View in: PubMed
    Score: 0.062
  9. Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States. J Infect Dis. 2025 Jan 08.
    View in: PubMed
    Score: 0.061
  10. Health Care Utilization and Clinical Management of All-Cause and Norovirus-Associated Acute Gastroenteritis Within a US Integrated Health Care System. Open Forum Infect Dis. 2024 Apr; 11(4):ofae151.
    View in: PubMed
    Score: 0.058
  11. Rotavirus Vaccine Impact Within an Integrated Healthcare Delivery System in the United States. J Pediatric Infect Dis Soc. 2022 Dec 28; 11(12):586-589.
    View in: PubMed
    Score: 0.053
  12. Norovirus and Other Viral Causes of Medically Attended Acute Gastroenteritis Across the Age Spectrum: Results from the Medically Attended Acute Gastroenteritis Study in the United States. Clin Infect Dis. 2021 Aug 16; 73(4):e913-e920.
    View in: PubMed
    Score: 0.048
  13. Rotavirus Vaccine Is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results From the Medically Attended Acute Gastroenteritis (MAAGE) Study. Clin Infect Dis. 2021 06 01; 72(11):2000-2005.
    View in: PubMed
    Score: 0.047

© 2025 Kaiser Permanente